Clinical Trial: Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb)

U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07543796) titled 'Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb)' on April 08.

Brief Summary: This is a phase IIa, multicenter ,randomized, double-blind, Double-Dummy, Active- and placebo-controlled study designed to evaluate the efficacy, safety and kinetic characteristics of TRD205 tablets for postoperative analgesia after unilateral hip arthroplasty

Study Start Date: March 18

Study Type: INTERVENTIONAL

Condition: Postoperative Analgesia After Unilateral Hip Arthroplasty

Intervention: DRUG: TRD205 Tablets, oral; 400 mg initial dose, then 200 mg q12h for 3 doses; total 4 dose...